Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)

Name: Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)
Published: 2021
License: Public Domain

Mirati Therapeutics Inc. · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

coloncancer colorectalcancer kras ras

advanced colorectal cancer, metastatic colorectal cancer, colorectal cancer, colorectal cancer trial, colorectal carcinoma, rectal cancer, colon cancer, kras, kras g12c, ras, colorectal adenocarcinoma, interventional

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)

Related documents